BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17543688)

  • 1. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
    Tatewaki H; Egashira K; Kimura S; Nishida T; Morita S; Tominaga R
    J Vasc Surg; 2007 Jun; 45(6):1236-43. PubMed ID: 17543688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
    Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys.
    Usui M; Egashira K; Ohtani K; Kataoka C; Ishibashi M; Hiasa K; Katoh M; Zhao Q; Kitamoto S; Takeshita A
    FASEB J; 2002 Nov; 16(13):1838-40. PubMed ID: 12223446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
    Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
    J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
    Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide.
    Ohno N; Itoh H; Ikeda T; Ueyama K; Yamahara K; Doi K; Yamashita J; Inoue M; Masatsugu K; Sawada N; Fukunaga Y; Sakaguchi S; Sone M; Yurugi T; Kook H; Komeda M; Nakao K
    Circulation; 2002 Apr; 105(14):1623-6. PubMed ID: 11940536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
    Saiura A; Sata M; Hiasa K; Kitamoto S; Washida M; Egashira K; Nagai R; Makuuchi M
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1886-90. PubMed ID: 15284091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease.
    Zhang X; Zhuang J; Wu H; Chen Z; Su J; Chen S; Chen J
    Ann Thorac Surg; 2010 Jul; 90(1):117-23. PubMed ID: 20609760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
    Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
    J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys.
    Nakano K; Egashira K; Ohtani K; Zhao G; Funakoshi K; Ihara Y; Sunagawa K
    Atherosclerosis; 2007 Oct; 194(2):309-16. PubMed ID: 17126840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits.
    Puhakka HL; Turunen P; Gruchala M; Bursill C; Heikura T; Vajanto I; Greaves DR; Channons K; Ylä-Herttuala S
    In Vivo; 2005; 19(3):515-21. PubMed ID: 15875770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
    Mujynya-Ludunge K; Viswambharan H; Driscoll R; Ming XF; von Segesser LK; Kappenberger L; Yang Z; Vassalli G
    Basic Res Cardiol; 2005 Mar; 100(2):102-11. PubMed ID: 15578196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells.
    Ohtani K; Egashira K; Hiasa K; Zhao Q; Kitamoto S; Ishibashi M; Usui M; Inoue S; Yonemitsu Y; Sueishi K; Sata M; Shibuya M; Sunagawa K
    Circulation; 2004 Oct; 110(16):2444-52. PubMed ID: 15477409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
    Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
    J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats.
    Kumai Y; Ooboshi H; Takada J; Kamouchi M; Kitazono T; Egashira K; Ibayashi S; Iida M
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1359-68. PubMed ID: 15625410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.